RecruitingNCT02023060
Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
Sponsor
Sheba Medical Center
Enrollment
100 participants
Start Date
Nov 1, 2013
Study Type
OBSERVATIONAL
Conditions
Summary
The objective is to observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.
Eligibility
Min Age: 18 YearsMax Age: 110 Years
Inclusion Criteria2
- Subject selected for transcatheter heart valve replacement
- Signed informed consent to participate in the study
Exclusion Criteria2
- Inability to sign written informed consent.
- Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02023060
Related Trials
Comparison of Evolut FX Versus Sapien 3 Ultra Resilia.
NCT064700221 location
Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock
NCT066382681 location
DELINEATE-Prospective
NCT071977361 location
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
NCT05646381139 locations
STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
NCT072783101 location